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Abstract. 
 
Molecules that couple the actin-based cy-
toskeleton to intracellular signaling pathways are cen-
tral to the processes of cellular morphogenesis and dif-
ferentiation. We have characterized a novel protein, 
the actin-binding LIM (abLIM) protein, which could 
mediate such interactions between actin filaments and 
cytoplasmic targets. abLIM protein consists of a COOH-
terminal cytoskeletal domain that is fused to an NH
 
2
 
-
terminal domain consisting of four double zinc finger 
 
motifs. The cytoskeletal domain is 
 
z
 
50% identical to 
erythrocyte dematin, an actin-bundling protein of the 
red cell membrane skeleton, while the zinc finger domains 
conform to the LIM motif consensus sequence. In vitro 
expression studies demonstrate that abLIM protein can 
bind to F-actin through the dematin-like domain. Tran-
scripts corresponding to three distinct isoforms have a 
widespread tissue distribution. However, a polypeptide 
corresponding to the full-length isoform is found exclu-
sively in the retina and is enriched in biochemical ex-
tracts of retinal rod inner segments. abLIM protein also 
undergoes extensive phosphorylation in light-adapted 
retinas in vivo, and its developmental expression in the 
retina coincides with the elaboration of photoreceptor 
inner and outer segments. Based on the composite pri-
mary structure of abLIM protein, actin-binding capac-
ity, potential regulation via phosphorylation, and isoform 
expression pattern, we speculate that abLIM may play 
a general role in bridging the actin-based cytoskeleton 
with an array of potential LIM protein-binding partners. 
The developmental time course of abLIM expression 
in the retina suggests that the retina-specific isoform 
may have a specialized role in the development or elab-
oration of photoreceptor inner and outer segments.
 
T
 
erminal
 
 differentiation and morphogenesis of
many vertebrate cell types involve a coordinated
program of intercellular interactions, transcriptional
regulation, and intracellular movements (Watanabe and
Raff, 1990; Altshuler et al., 1991; Saha et al., 1992; Wil-
liams and Goldwitz, 1992; Adler, 1993; Beebe, 1994). Pho-
toreceptor cells, in particular, undergo a complex process
of cellular morphogenesis that segregates the phototrans-
duction apparatus from other cellular components and re-
sults in a highly polarized adult morphology. This morpho-
genetic process is largely reiterated in the daily renewal
cycle of outer segment membrane structure throughout
adult life (Young, 1967). The central importance of dy-
namic cytoskeletal interactions in both the initial assembly
of the photoreceptor outer segment and the daily mem-
brane renewal cycle of photoreceptor cells (Williams et al.,
1988; Vaughan and Fisher, 1989) suggests that structural
elements such as microfilaments and/or microtubules might
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act in combination with photoreceptor-specific cytoskele-
tal proteins to control and coordinate membrane move-
ments. An initial search for photoreceptor-specific cyto-
skeletal elements in the retina led to the discovery of a
cytoskeletal protein that is highly concentrated near the
sites of membrane assembly (Roof et al., 1991) and is re-
lated to erythrocyte dematin (Rana et al., 1993).
Dematin and dematin-like proteins have previously
been proposed to participate in dynamic regulation of cel-
lular processes through reversible modulation of the actin-
associated membrane skeleton (Koury et al., 1989; Frie-
derich et al., 1992; Mahajan-Miklos and Cooley, 1994). Both
the 48- and 52-kD subunits of erythrocyte dematin contain
a headpiece domain, similar to the headpiece domain of
villin, that binds actin filaments (Rana et al., 1993; Azim et
al., 1995). In addition, the dematin headpiece domain is es-
sential for actin-bundling activity, which can be reversibly
modulated by phosphorylation (Husain-Chishti et al.,
1988). Such activity has been proposed to play a key role
in erythroid development. These potential roles for dema-
tin-like proteins in cytoskeletal regulation and cellular
morphogenesis prompted us to search for dematin homo-
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logues in the vertebrate retina using a molecular cloning
strategy.
We report here the characterization of a novel retinal
protein, which we term the actin-binding LIM (abLIM)
 
1
 
protein. abLIM protein has a complex primary structure,
with a cytoskeletal dematin-like domain that is fused to a
second domain composed of four double zinc finger mo-
tifs. The double zinc fingers are cysteine-rich domains that
conform to the consensus sequence previously described
for LIM motifs: CX
 
2
 
CX
 
16–23
 
HX
 
2
 
CX
 
2
 
CX
 
2
 
CX
 
16–21
 
CX
 
2
 
C/H/
D (Schmeichel and Beckerle, 1994). LIM motifs, which
were named for the three proteins in which they were orig-
inally identified: Lin-11 (Freyd et al., 1990), Isl-1 (Karlsson
et al., 1990), and Mec-3 (Way and Chalfie, 1988), have
been identified in 
 
.
 
 35 proteins to date (see Sadler et al.,
1992; Crawford et al., 1994; Taira et al., 1995; Dawid et al.,
1995). The potential importance of the LIM motifs is sug-
gested by the properties of other LIM-containing proteins.
Like the three original members of the LIM family, other
members of the LIM/homeodomain family such as Xlim-
1,-2,-3 (Taira et al., 1993, 1994), apterous (Cohen et al.,
1992), LH-2 (Xu et al., 1993), P-Lim/Lhx3 (Bach et al.,
1995; Sheng et al., 1996), lmx-1 (German et al., 1992), Isl-2
(Tsuchida et al., 1994), LIM1 (Tsuchida et al., 1994;
Shawlot and Behringer, 1995), and LIM3 (Tsuchida et al.,
1994) are all involved in the implementation of a diverse
array of developmental programs. However, it is now
known that LIM motifs are also found in non-homeo-
domain proteins. Among these non-homeodomain LIM
proteins are the LIM-only proteins rhombotin2 (Ttg)
(Warren et al., 1994) and MLP (Arber et al., 1994), two
proteins that are explicitly involved in cellular differentia-
tion in erythroid and muscle cells, respectively. Another
category of non-homeodomain LIM proteins includes pax-
illin (Salgia et al., 1995) and zyxin (Sadler et al., 1992;
Crawford et al., 1994), two proteins that associate with the
cytoskeleton through specific interactions with vinculin/
talin or 
 
a
 
-actinin and are thought to modulate cell adhe-
sion–stimulated changes in gene expression. Furthermore,
the expression of a wide range of other LIM proteins has
been implicated in cellular senescence and/or malignant
transformation (Royer-Pokora et al., 1991; Wang et al., 1992;
Shibanuma et al., 1994; Kiess et al., 1995; Weiskirchen et
al., 1995). In view of the wide phylogenetic distribution of
LIM proteins, from yeast (Mueller et al., 1994) to humans,
and the involvement of many LIM proteins in develop-
ment, differentiation, and/or growth control, it has been
suggested that LIM motifs may play a fundamental role as
cellular regulatory sequences, through modulation of a va-
riety of protein–protein interactions (Schmeichel and
Beckerle, 1994). The discovery of a novel protein with a
dematin-like domain in combination with multiple LIM
motifs opens the possibility that abLIM protein may play
multiple roles in establishing and maintaining cellular
structure through a bifunctional cross-linking with multi-
ple LIM-binding partners.
 
Materials and Methods
 
cDNA Cloning
 
An adult human retinal cDNA library (Clontech, Palo Alto, CA) was ini-
tially screened at low stringency by standard hybridization methods (Sam-
brook et al., 1989) using a 
 
32
 
P-labeled full-length dematin cDNA probe
(Rana et al., 1993). Additional rounds of library screening were per-
formed using abLIM gene sequences. Selected cDNA inserts were either
subcloned into pBluescript (Stratagene, La Jolla, CA) or amplified by
PCR. Both sense and antisense strand sequences were obtained for the
entire abLIM coding region. 5
 
9
 
 rapid amplification of cDNA ends
(RACE; Frohman et al., 1988) was used to obtain the extreme 38 bp at the
5
 
9
 
 end of the transcript. The RACE procedure was carried out on retina-
and brain-derived polyA
 
1
 
 RNA using the 5
 
9
 
-ampliFINDER RACE and
Marathon cDNA amplification kits (Clontech) as per the manufacturer’s
protocols. RACE products were either sequenced directly after purifica-
tion or, in some cases, subcloned into a plasmid vector followed by se-
quencing of multiple clones.
Nucleotide and amino acid sequences were analyzed using DNAsis/HI-
BIO software (Hitachi Software Engineering America, San Bruno, CA).
BLAST sequence homology searches were performed against the Swiss-
Prot, PIR, DDBJ, and GenBank databases (Altschul et al., 1990). With
one exception, all numbering of nucleotide and amino acid sequences is
referenced to the longest abLIM isoform sequence (abLIM-l). A different
numbering is assigned to the extreme 5
 
9 
 
untranslated region (UTR) of
abLIM-s, which is unique to this isoform and is identical to a previously
identified transcript. (These sequence data are available from DDBJ un-
der accession number D31883.) The unique 5
 
9
 
 UTR consists of the follow-
ing sequence inserted 5
 
9
 
 to nucleotide (nt) 1,012 in the abLIM-l sequence:
(
 
2
 
164) GAGAGAAGCCTGATATGTAACCCAGGCGGGTGGGAG-
CCTCAGTCTGTCGGGCTGAGGTCTGGCATCTACAAAGCCTCTTG-
GCCGTGTTCTGAACTTGAAGCCTGGAGGAGTTCTCTGCTCAGC-
ACAGCCAAGGAACAGAATTAGAAGAAAAGGAACCCTGGCCT
(
 
2
 
1). The numbering of the inserted unique 5
 
9
 
 UTR sequence is indicated
in parentheses.
 
Northern Blots
 
RNA preparations from human liver, cardiac muscle, skeletal muscle,
brain, and retina (Clontech) were initially analyzed on Northern blots us-
ing standard procedures (Sambrook et al., 1989) and a 
 
32
 
P-labeled abLIM
probe (nt 1,687–2,587). RNA from selected tissues was further analyzed
using two shorter probes. One of the short probes included nt 
 
2
 
144 of
the unique abLIM-s 5
 
9
 
 UTR sequence (see above) through nt 1,028 of the
abLIM sequence. This is identical to a sequence (nt 21–180) from the
cDNA previously identified as accession number D31883 (DDBJ). A sec-
ond short probe included nt 106–501 from the abLIM sequence. These
two short probes were designed to detect sequences present in either
abLIM-s or abLIM-l RNAs, respectively.
 
Reverse Transcription–PCR on Tissue RNAs
 
First strand cDNAs were synthesized from polyA
 
1
 
 RNAs from various
tissues or cultured cells with oligo(dT) priming using Superscript reverse
transcriptase (GIBCO BRL, Gaithersburg, MD). The 369-bp product am-
plified specifically from abLIM-s sequences (designated PCR 1) was gen-
erated using a nested set of primer pairs. First round amplification primers
corresponded to abLIM-s sequences: (sense) nt 
 
2
 
114 through nt 
 
2
 
95 and
(antisense) nt 1,656–1,682. Second round amplification primers corre-
sponded to abLIM sequences (sense) nt 1,407–1,426 and (antisense) nt
1,057–1,084. Sequences of primer pairs used to amplify the 729-bp product
derived exclusively from the abLIM-l sequence (designated PCR 2) are:
(sense) nt 285–312 and (antisense) nt 983–1,014.
 
Tissue Preparation, SDS-PAGE and
Western Immunoblots
 
Freshly dissected samples of mouse organs (liver, kidney, lung, brain, car-
diac muscle, and retina) were minced and placed into 5 mM Hepes, pH
7.5, 1 mM DTT, and a protease inhibitor cocktail previously described
(Roof et al., 1991). The tissue was immediately homogenized and briefly
sonicated. An equal volume of 68% sucrose in 10 mM Tris, pH 7.5, 1 mM
MgCl
 
2
 
, 60 mM NaCl was added and the sample was centrifuged at 1,600 
 
g
 
,
at 4
 
8
 
C for 5 min. The nuclear pellet was discarded, and the supernatant
 
1. 
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glial fibrillary acidic protein; nt, nucleotide; RACE, rapid amplification of
cDNA ends; RIS, rod inner segment; ROS, rod outer segment; RT, re-
verse transcription; UTR, untranslated region. 
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was diluted with an equal volume of 1% Triton X-100 in 10 mM Tris, pH
7.5, 1 mM MgCl
 
2
 
, 60 mM NaCl and centrifuged at 52,000 
 
g
 
 for 15 min at 4
 
8
 
C.
The cytoskeletal extract was washed in 1% Triton X-100, 10 mM Tris, pH
7.5, 1 mM MgCl
 
2
 
, 60 mM NaCl, resuspended in sample buffer (Laemmli,
1970), and cleared by brief low speed centrifugation.
Retinal rod inner and outer segment fractions were prepared as previ-
ously described (Papermaster and Dreyer, 1974; Roof et al., 1991). The re-
spective fractions were collected by high speed centrifugation and either
dissolved in SDS-PAGE sample buffer or resuspended in 0.1 M Tris, pH
8.0, 1 mM PMSF for subsequent alkaline phosphatase digestion. Polypep-
tides were separated using 7.5% SDS-PAGE (Laemmli, 1970) and elec-
trophoretically transferred to polyvinylidene difluoride membranes (Mil-
lipore Corp., Bedford, MA) (Towbin et al., 1979). Gel lanes that were not
blotted were stained either with silver (Wray et al., 1981) or Coomassie
brilliant blue R250. Blots were incubated in primary antisera or preim-
mune sera at 1:5,000–1:10,000 and developed according to the manufac-
turer’s specifications using a peroxidase-conjugated chemiluminescent
secondary antibody system (Boehringer Mannheim Biochemicals, India-
napolis, IN).
Frozen human tissue samples with postmortem intervals up to 11 h
were obtained from the National Disease Research Interchange (Be-
thesda, MD). Extracts from liver, kidney, skeletal muscle, and brain
(white matter) were processed as described above, analyzed by SDS-
PAGE, and immunoblotted using abLIM-specific antibodies. Specific
abLIM polypeptides were identified on immunoblots as a ladder of multi-
ple high mobility bands, a pattern characteristic of extensive proteolysis.
Because of this apparent proteolysis, human tissue was not used for fur-
ther analysis.
 
Enzymatic Digestion of Retinal Membranes
 
Inner segment–enriched fractions of retinal membranes were digested
with 20 U of alkaline phosphatase (calf intestine; New England Biolabs,
Beverly, MA) in 20 
 
m
 
l of 0.1 M Tris, pH 8.0, 1 mM PMSF. Control mem-
branes were digested in an equivalent volume of 0.1 M sodium phos-
phates, pH 8.0, 1 mM PMSF. Samples were incubated for 15 min, 30 min, or
1 h at 30
 
8
 
C and subsequently analyzed by SDS-PAGE and immunoblotting.
Equivalent amounts of inner segment preparations were digested with
either endoglycosidase H at 2 U per sample (Boehringer Mannheim Bio-
chemicals) or endoglycosidase F/N-glycosidase F at 0.2 U per sample
(Boehringer Mannheim Biochemicals) in 0.02 M sodium acetate buffer,
pH 5.3, 0.1 M NaCl, 0.5 mM MgCl
 
2
 
, and 0.5% Triton X-100. Glycosidase-
treated samples and an untreated control sample were incubated for 3 h at
30
 
8
 
C. Samples were analyzed by SDS-PAGE and immunoblotting. To val-
idate the effectiveness of the enzyme treatments on a known glycosylated
substrate, rhodopsin, the immunoblots initially stained with abLIM anti-
bodies were washed and restained with anti-rhodopsin mAbs (rho 1D4)
(MacKenzie et al., 1984). The apparent shift to higher mobility of the op-
sin polypeptide indicated complete deglycosylation under the conditions
used for abLIM analysis (data not shown).
 
In Vitro Expression of abLIM Polypeptides
 
Two glutathione-S-transferase (GST) fusion constructs were generated by
subcloning fragments of the abLIM sequence in frame into the pGEX4T-2
plasmid expression vector (Pharmacia Biotech Inc., Piscataway, NJ). One
construct (GST–dem) corresponds to amino acids 585–778 of the abLIM
sequence and a second construct (GST–LIM) corresponds to abLIM
amino acids 58–294. Fusion proteins were expressed in 
 
Escherichia coli
 
(Smith and Johnson, 1988) and purified using glutathione agarose accord-
ing to the manufacturer’s instructions (Pharmacia Biotech Inc.). Aliquots
of the fusion proteins were checked by digestion with thrombin. Each ex-
pressed protein had the correct expected mobility on SDS polyacrylamide
gels both before and after thrombin digestion. A GST fusion construct
that included the entire abLIM-l coding sequence was also generated and
transformants were identified. However, no expressed protein could be
recovered from these transformants.
A construct containing the entire coding sequence of abLIM-l with
 
z
 
0.2 kb of the 3
 
9
 
 UTR was prepared from two overlapping phage inserts
cloned into pBluescript SK(
 
1
 
) (Stratagene). abLIM-m and -s clones were
derived from the abLIM-l clone by appropriate modification of the 5
 
9
 
 end
of the cloned insert. Clones containing the correct abLIM-l, -m, and -s
fragments were identified on the basis of insert size and PCR amplifica-
tion using sequence specific primers. The identity of the clones was con-
firmed by sequencing across the vector–insert junction into the NH
 
2
 
-ter-
minal coding region. DNA from each of the clones containing abLIM-s, -m,
or -l sequences was purified using CsCl equilibrium gradient centrifuga-
tion (Sambrook et al., 1989). Polypeptides derived from the abLIM-l, -m,
and -s constructs were synthesized and labeled with [
 
35
 
S]methionine using
the TNT-coupled reticulocyte lysate system (Promega, Madison, WI) with
or without added microsomal membranes.
 
Actin-binding Assay
 
Actin was isolated from rabbit skeletal muscle (Spudich and Watt, 1971)
and further purified by gel filtration on a Sephacryl 300 column. The ac-
tin-binding assay was performed as previously described (Azim et al.,
1995) in a total vol of 60 
 
m
 
l with 
 
z
 
2.5–8 
 
m
 
g of each fusion protein added to
each assay mixture. Actin was added to a final concentration of 240 
 
m
 
g/ml.
The actin-binding assay was also performed using 
 
35
 
S-labeled expression
products derived from the abLIM-s, -m, and -l clones (see above). Crude
TNT reaction mixes containing the expressed polypeptides were pre-
cleared by centrifugation and 2.5 
 
m
 
l of the supernatant was added to a to-
tal vol of 60 
 
m
 
l, which included a 1:100 dilution of protease inhibitor solu-
tion (Pefabloc, leupeptin; Boehringer Mannheim Biochemicals).
Quantitative analysis of actin binding to the carboxy-terminal region of
abLIM (amino acids 585–778) was performed using the GST–dem fusion
protein with expressed GST as a negative control. Assay mixtures (60 
 
m
 
l)
contained a total of fusion protein (either GST–dem or GST) equal to: 0,
1.8, 2.7, 3.5, 10.6, 14.2, or 21.3 
 
m
 
g. The relative amount of protein present
in the appropriate bands in the supernatant and pellet fractions was quan-
titated by scanning the Coomassie-stained SDS gel. The amount of GST–
dem in the pellet fraction was used to determine the concentration of fu-
sion protein bound to F-actin. Values for the amount of free GST–dem in
each fraction were calculated by subtraction of the bound abLIM values
from the known total amount of GST–abLIM added to each reaction
tube, assuming 100% recovery in the pellet plus supernatant fractions.
The amount of F-actin recovered in each pellet fraction was constant and
equivalent to 11.6 
 
m
 
g. Binding parameters, including the maximal binding
stoichiometry of GST–dem to F-actin and equilibrium dissociation con-
stant (
 
K
 
d
 
), were calculated using the program Enzfitter (Biosoft, Fergu-
son, MO).
 
Antibody Preparation and Immunofluorescence
 
The purified GST–dem fusion protein was used to prepare antisera in two
rabbits (Eastacres Biologicals, Southbridge, MA). Selected blots and tis-
sue sections were stained with serum that was preabsorbed against crude
liver membranes to reduce nonspecific background staining, or preab-
sorbed with an excess of purified expressed GST protein to rule out possi-
ble reactivity with the GST portion of the fusion protein. Preabsorption of
the serum with the GST–dem fusion protein eliminated antibody binding
to tissue sections and to abLIM polypeptides on immunoblots. To pre-
serve antigenicity, samples of adult mouse eyes and cardiac muscle were
embedded without fixation directly into Tissue-Tek O.C.T. compound
(Miles Inc., Elkhart, IN) and 6-
 
m
 
m cryostat sections were prepared. Sec-
tions were processed for immunofluorescence as previously described
(Roof et al., 1991). mAbs specific for 
 
a
 
-actinin were obtained commer-
cially (clone EA-53; Sigma Chemical Co., St. Louis, MO). Cy3-conjugated
secondary antibodies were obtained from Jackson ImmunoResearch Lab-
oratories, Inc. (West Grove, PA). BODIPY FL™ phallacidin and BO-
DIPY™-conjugated anti–mouse IgG were obtained from Molecular
Probes, Inc. (Eugene, OR). All samples were viewed with indirect fluores-
cence and differential interference contrast optics and photographed us-
ing TMAX400 film (Eastman Kodak Co., Rochester, NY). Selected sam-
ples of retina and cardiac muscle were viewed using a confocal laser
scanning microscope (TCS4D; Leica, Malvern, PA).
 
Results
 
Molecular Cloning of abLIM
 
To obtain clones that encode dematin-like polypeptides in
the retina, a human retinal cDNA library was screened at
reduced stringency using a probe corresponding to the
full-length coding sequence of human erythrocyte dematin
(Rana et al., 1993). A group of overlapping clones was iso-
lated that represented a novel transcript with homology to 
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dematin. In the first round of screening, two cDNA inserts
were sequenced and one of these spanned the junction be-
tween the dematin-like and LIM domains. A second round
of library screening using sequence-specific probes at high
stringency generated four additional clones that spanned
the dematin/LIM domain junction. A third round of screen-
ing using sequence-specific probes provided three addi-
tional clones that confirmed the dematin/LIM domain
junction, two clones that contained the putative transla-
tion start site, and one clone that was subsequently found
to contain all but the ultimate 38 bp at the extreme 5
 
9
 
 end
of the cDNA sequence.
Approximately 40 bp at the extreme 5
 
9
 
 end of the puta-
tive transcript were not present in any of the cDNA clones
and were provided by subsequent 5
 
9
 
 RACE (Frohman et
al., 1988) using sequence-specific primers (Fig. 1, 
 
arrow
 
).
The site of translation initiation is inferred from the pres-
ence of an in-frame stop codon 5
 
9
 
 to the putative methio-
nine initiation codon. An open reading frame of 2,334 bp
encodes a polypeptide of 778 amino acids with a predicted
mass of 87.7 kD (Fig. 1). This polypeptide was named ac-
tin-binding LIM, or abLIM, protein based on two features
of its primary sequence (see below).
An RNA species of 
 
z
 
7.7 kb is detected on Northern
blots from liver, heart, skeletal muscle, brain, and retina
using a probe derived from the COOH-terminal half of
the abLIM coding sequence (Fig. 2). This is consistent
with a coding sequence for the translated protein of 
 
z
 
2.4
kb with a large (
 
z
 
5.1 kb) 3
 
9
 
 UTR.
No related transcripts were identified during the retinal
library screens. However, subsequent analysis provided
evidence that at least two such additional transcripts exist.
Homology search of the available nucleotide databases
identified a cDNA sequence that is derived from an imma-
ture myeloid cell line and is nearly identical to the COOH-
terminal part of the retinal abLIM cDNA, from nucleotide
position 1012 through the 3
 
9
 
 end of the transcript. The
abLIM sequence differs from the previously reported se-
quence (DDBJ, accession number D31883) at only five,
presumably polymorphic, sites within the coding region.
The D31883 sequence also includes a large (
 
z
 
5 kb) 3
 
9
 
UTR for which the complete sequence is available and a
unique region of 5
 
9
 
 UTR (for complete 5
 
9
 
 UTR sequence,
see Materials and Methods). The abLIM and D31883
matching sequences encode a polypeptide of 461 amino
acids that corresponds to the dematin-like region of
abLIM, excluding the LIM motifs. To test the hypothesis
that this is a bona fide transcript representing a short iso-
form of abLIM, we used primers derived from the unique
5
 
9
 
 UTR of the D31883 cDNA (see Materials and Meth-
ods) to analyze reverse-transcribed cDNAs in a variety of
tissues and cell lines (Fig. 3 
 
a
 
). The reverse transcription
(RT)–PCR analysis verified the presence of the small iso-
form transcript (Fig. 3 
 
a
 
, 
 
PCR 1
 
) in every tissue and cell
line tested, including retina. The deduced polypeptide was
subsequently designated abLIM-s to distinguish it from
abLIM-l, the isoform originally cloned from the retinal li-
brary. A second PCR product of 
 
z
 
450 bp was amplified
from liver, suggesting that there may be additional, as yet
undiscovered, abLIM isoforms or homologues in some tis-
sues.
abLIM-s expression in selected tissues was further ana-
lyzed using Northern blots probed with a sequence that is
unique to the 5
 
9
 
 UTR of abLIM-s (Fig. 3 
 
b
 
, 
 
abLIM-s
probe
 
). Fig. 3 
 
c
 
 (
 
left
 
) shows a closely spaced doublet of
 
z
 
6.7 kb that corresponds to abLIM-s RNAs. The levels of
Figure 1. Nucleotide and derived amino acid sequences of
abLIM. Translation initiation sites for the three isoforms are indi-
cated by the circled methionine residues. The abLIM-s isoform
contains a unique 59 UTR that consists of 164 nt inserted 59 to nt
1,012 and numbered 21 to 2164 (see Materials and Methods).
The four LIM domains are shaded, the sequence that is deleted in
the abLIM-m isoform is underlined, and the 38–amino acid poly-
morphism (variably present in all isoforms) is indicated by a
dashed underline. (Arrow) Sequence provided by 59 RACE.
These sequence data are available from GenBank/EMBL/DDBJ
under accession number AF005654. 
Roof et al. 
 
abLIM, an Actin-binding Double Zinc Finger Protein
 
579
 
abLIM-s transcript are approximately equivalent in brain,
skeletal muscle, and retina. The two closely spaced bands
in the doublet probably represent a polymorphism that
was originally detected among the various retinal cDNA
clones (see Fig. 1, 
 
dashed underline
 
).
The tissue distribution of the abLIM-l transcript was ex-
amined using RT-PCR with multiple primer pairs selected
to span the portion of the 5
 
9
 
 end of the abLIM-l sequence
that is unique to this isoform. Fig. 3 
 
a
 
 (
 
right
 
) shows an ex-
ample of the results using a specific primer pair that ampli-
fied the appropriate sequence, designated PCR 2, in
cDNA derived from human retina, but not from brain or
the two cell lines. Northern blot analysis using a probe de-
rived exclusively from the abLIM-l sequence (Fig. 3 
 
b
 
,
 
abLIM-l probe
 
) identifies an RNA species with slightly
lower mobility than the abLIM-s RNA (Fig. 3 
 
c
 
, 
 
right
 
).
The predicted size difference between the abLIM-s and
abLIM-l RNAs is 
 
z
 
0.9 kb, consistent with their relative
mobilities on the Northern blot (Fig. 3 
 
c
 
). Also consistent
with the PCR analysis is the finding that abLIM-l is a rela-
tively minor transcript within brain RNAs. However, the
abLIM-l transcript is apparently not unique to the retina,
but is also present in substantial amounts in other tissues,
including skeletal muscle.
Evidence for the existence of yet another abLIM tran-
script of intermediate length comes from direct sequenc-
ing of products derived from 5
 
9
 
 RACE. A RACE product
smaller than the predicted size of abLIM-l was amplified
from brain-derived cDNAs using a 5
 
9
 
 anchor primer and a
gene-specific primer complementary to abLIM nucle-
otides 1,077–1,096. To determine whether this intermedi-
ate-sized product represents a genuine transcript in vivo,
the sequence was subsequently amplified from both retina
and brain cDNAs using a 5
 
9
 
 anchor primer and an abLIM-
specific primer complementary to nt 984–1,014 (Fig. 1).
The sequence of the amplified product corresponds to an
intermediate-sized abLIM isoform, designated abLIM-m,
which is missing nt 21–501 near the abLIM-l NH2 terminus
(see Fig. 1 a, underlined sequence). Since abLIM-m and
abLIM-l share sequences within the extreme 59 UTR, they
are most likely products derived via alternative splicing.
Homologies of abLIM Protein to Known
Functional Domains
The general structure of the two largest abLIM isoforms
deduced from the cDNA sequences is a linear combina-
tion of two structurally and functionally distinct domains,
each representing about half of the total length of the pro-
Figure 2. Northern blot of abLIM sequences. PolyA1 RNAs
from liver, heart, skeletal muscle, brain, and retina were loaded
at 0.5 mg per lane and probed with a 32P-labeled abLIM cDNA
sequence shared by all abLIM isoforms (nt 1,687–2,587). Size
markers are indicated.
Figure 3. Characterization of multiple abLIM transcripts. (a) Iso-
form-specific primer pairs were used in RT-PCR analysis of
mRNA isolated from retina, brain, heart, liver, and two different
cell lines, LA-N1 (Seeger et al., 1977) and 293 (Graham et al.,
1977) cells. Primers that specifically amplify a sequence from
abLIM-s (PCR 1) are indicated by open arrowheads in b. All tis-
sues and cell lines tested gave the expected 369-bp PCR 1 prod-
uct (a, open arrowhead, left), indicating the widespread presence
of the abLIM-s transcript. A product of z450 bp was amplified
from liver, suggesting that there may be additional abLIM iso-
forms or homologues in some tissues. Primers that specifically
amplify a sequence from abLIM-l (PCR 2) are indicated by filled
arrowheads in b. The appropriate 729-bp PCR 2 product is ampli-
fied only from retina (a, filled arrowhead, right). Exact primer se-
quences for PCR 1 and PCR 2 are given in Materials and Meth-
ods. (c) Northern blot of polyA1 RNAs (z1 mg per lane) from
human brain, skeletal muscle, and retina using probes unique to
the abLIM-s or -l transcripts. Left three lanes were incubated
with the probe specific for abLIM-s sequences (described in Ma-
terials and Methods). Right three lanes were probed with se-
quences present only in the abLIM-l isoform. Size markers are in-
dicated to the left of each gel (bp). Primer sequences used to
generate the probes are given in Materials and Methods. TE,
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tein (Fig. 4 a). The COOH-terminal domain of abLIM-m
and -l isoforms, as well as the complete sequence of
abLIM-s, are z50% identical to dematin, an actin-bun-
dling protein from the human erythrocyte membrane skel-
eton (Rana et al., 1993) (Fig. 4 a). Only a few specific func-
tional aspects of the dematin sequence appear to be
conserved in abLIM. A portion of the actin-binding region
of dematin at the extreme COOH terminus (dematin
amino acid residues 340–383; Rana et al., 1993) is highly
conserved in the abLIM polypeptides (abLIM amino acid
residues 735–778; Fig. 4 a, VILLIN). This region corre-
sponds to a previously described sequence within the
headpiece of villin (Friederich et al., 1992) that shares
some homology with the product of a Drosophila villin-
like gene, quail (Mahajan-Miklos et al., 1994). These se-
quences are thought to be directly involved in the binding
of both dematin and villin to actin filaments. In contrast,
most of the other key features of the dematin primary se-
quence are not conserved in the abLIM proteins (Rana et
al., 1993). The ability of dematin to form trimers is be-
lieved to be mediated by a single essential cysteine residue
at amino acid position 194 of the dematin sequence. This
cysteine is not conserved in the abLIM sequence, which
has no cysteine residues within the region of dematin ho-
mology. Other features of the dematin sequence that are
absent from the abLIM protein primary sequence are a
PEST sequence that may be involved in rapid intracellular
turnover of dematin and a putative polyglutamate nuclear
localization sequence.
The amino-terminal domains of abLIM-m and abLIM-l
are highly cysteine rich, moderately glycine rich, and con-
tain three or four copies, respectively, of a cysteine and
histidine–containing domain termed the LIM motif. The
LIM motif has the backbone consensus sequence indi-
cated at the bottom of Fig. 4 b. The four LIM motifs from
abLIM protein are compared with each other and with
LIM domains from paxillin (Fig. 4 b), another cytoskele-
ton-associated LIM protein that also contains four LIM
domains. In contrast with paxillin and other cytoskeletal
LIM proteins with multiple COOH-terminal LIM do-
mains (Sadler et al., 1992; Salgia et al., 1995; Kuroda et al.,
1996), the LIM motifs in abLIM are clustered near its
amino terminus. Three of the four LIM motifs from
abLIM show perfect agreement with the Cys/His/Asp back-
bone consensus sequence. The carboxy-terminal-most LIM
domain is imperfect at the penultimate Cys residue, which
is a His residue in this variant. Comparison with a wide
range of LIM motifs from a variety of species and tissues
suggests that there is general conservation of hydrophobic
residues at the six additional positions indicated in Fig. 4 b.
Further conservation of four out of six glycines and a sin-
gle lysine is observed among the four LIM domains of
abLIM protein.
All Three abLIM Isoforms Can Bind to Actin Filaments
The function of abLIM protein, particularly within some
restricted subcellular locales, may be related to its ability
to bind to actin filaments. This property is strongly pre-
dicted from abLIM sequence homology with the known
actin-binding proteins, erythrocyte dematin and villin. To
verify that abLIM indeed binds actin, all three abLIM iso-
forms were expressed in vitro using a reticulocyte lysate
system, and the actin-binding ability of each expressed iso-
form was tested independently (Fig. 5). In each case, the
presence of actin in the reaction mixture shifted the ex-
pressed polypeptides from the supernatant to the pellet
fraction. This indicates that all three abLIM isoforms have
the capacity to bind to actin filaments in vitro.
The Dematin Homology Region of abLIM Binds Actin
The sequence homology between abLIM and other actin-
binding proteins predicts that it is the dematin-like domain
of abLIM that is responsible for the observed actin bind-
ing. To test this prediction, two different sequences de-
rived from abLIM protein, one that contained the dema-
tin/villin headpiece region and one that included all four
LIM domains (see Materials and Methods), were ex-
pressed as GST fusion proteins in E. coli. The two purified
fusion proteins as well as the GST-only expression protein
were tested for binding to actin filaments in vitro. In this
assay, GST and the two fusion proteins are all found in the
supernatant fraction when actin is not present in the assay
mix (Fig. 6). However, only the abLIM construct derived
from the dematin/villin homology region (GST–dem) is
found in the pellet fraction when the samples are coincu-
bated with actin under polymerizing conditions (Fig. 6).
Figure 4. Structure of the abLIM polypeptides. (a) Diagrams of
the protein structures of three abLIM isoforms. Features indi-
cated in the protein sequence are: VILLIN, homology to both de-
matin and the villin headpiece; DEMATIN-undefined, homology
to the “undefined” domain of dematin; LIM1–4, LIM motifs. To-
gether, the VILLIN 1 DEMATIN-undefined regions make up
the dematin-like region of abLIM. (b) Sequence comparison of
the four LIM domains from paxillin and abLIM protein. The
LIM consensus sequence is indicated at the bottom of the figure.
Conserved C/H/D residues within the LIM backbone are indi-
cated by dark shading, conserved hydrophobic residues are indi-
cated by light shading, and residues conserved only within the
four abLIM protein LIM domains are indicated by unshaded
boxes.Roof et al. abLIM, an Actin-binding Double Zinc Finger Protein 581
Neither the LIM region fusion protein (GST–LIM) nor
GST showed significant F-actin–binding ability. This dem-
onstrates a relatively specific interaction between F-actin
and the dematin-like sequences of abLIM protein.
To date, it has not been possible to express the full-
length abLIM sequence in vitro as a GST fusion protein.
However, the actin-binding affinity and stoichiometry of
the shorter expressed GST–dem construct were estimated
by quantitative application of the sedimentation assay de-
scribed above (Fig. 7). The calculated dissociation con-
stant for the abLIM/F–actin interaction is z2.6 mM, as-
suming a single binding site and a molecular mass for
abLIM equal to the abLIM (amino acids 585–778) plus the
GST polypeptide. The maximal binding stoichiometry of
abLIM is approximately one GST–abLIM monomer per
1.1 actin molecules.
Comparison of abLIM Polypeptides Expressed In Vitro 
and In Vivo
To further define the expression pattern and size of all
abLIM isoforms, the three isoforms expressed in vitro
were compared with their counterparts expressed in vivo
in various tissues (Fig. 8 a). The tissue variants of abLIM
were detected on Western blots using an antibody that is
specific for the COOH-terminal dematin homology se-
quence that is common to all abLIM proteins (amino acids
585–778). The abLIM-specific antibody used in these stud-
ies was tested for reactivity with human erythrocyte dema-
tin to exclude any possible cross-reactivity on Western
blots with either the 48- or 52-kD dematin polypeptides
(data not shown). Although the antibody was prepared us-
ing a GST fusion protein derived from the human abLIM
sequence, the deduced murine abLIM amino acid se-
quence was subsequently found to be highly conserved
(93% identical to the human sequence) within this region.
The expressed human abLIM polypeptides are com-
pared in Fig. 8 a (lanes 1–3) with the respective murine
abLIM polypeptides in retina, heart, and brain extracts
(Fig. 8 a, lanes 5–7). On Western blots of all tissue ex-
tracts, abLIM-m is detected as a polypeptide doublet of
z75 kD. It seems likely that the two polypeptides of the
doublet may arise from a short 114 base sequence that is
apparently variably spliced into the dematin region of
abLIM protein (see Fig. 1 a, dashed underline).
In contrast, a polypeptide of z105 kD was identified ex-
clusively in membrane extracts from murine retinas (Fig. 8
a,  RIS). The 105-kD polypeptide, which corresponds to
the largest identified cDNA sequence, is not detected in
brain, lung, liver, kidney, or cardiac muscle extracts (Fig.
8, a and c). Further separation of retinal extracts into pho-
toreceptor inner and outer segment fractions suggests that
abLIM-l is not present in the light-sensing organelle, the
rod outer segment, but is enriched in rod inner segment
(RIS) extracts (Fig. 8 b). Thus, despite the apparent lack
of tissue specificity at the level of expression of the abLIM-l
RNA transcript (Fig. 3 c), the abLIM-l polypeptide is de-
tected only in extracts from retinal cells.
The smallest isoform of abLIM protein, which contains
only the dematin homology domain and none of the LIM
motifs, is not expressed at comparable levels in extracts
from murine heart, brain, retina (Fig. 8 a), liver, kidney, or
lung (Fig. 8 c). It is likely that abLIM-s is expressed at low
abundance in these tissues, consistent with the presence of
z60-kD products on overloaded immunoblots (Fig. 8 c).
However, the presence of additional minor proteolytic
products, particularly in the extracts from brain and lung,
obscures the further analysis of a putative abLIM-s poly-
peptide.
Posttranslational Modifications of abLIM
The three isoforms of abLIM protein have predicted
masses of 52.7, 70.6, and 87.7 kD, respectively. It is notable
that the apparent sizes of the abLIM-l, -m, and -s polypep-
Figure 5. Actin binding to three abLIM isoforms expressed in
vitro. Polypeptides expressed in vitro using constructs corre-
sponding to abLIM-l, abLIM-m, and abLIM-s were tested for
their ability to bind to actin filaments. All three isoforms cosedi-
ment with F-actin (1actin) and are found primarily in the respec-
tive pellet fractions (P). Each isoform is found in the supernatant
fraction (S) when actin is not present in the assay mixture
(2actin). Nonspecific binding to the GST-only polypeptide was
negligible at all concentrations (data not shown). Approximate
Mr (kD) of each isoform is indicated at left.
Figure 6. Actin binding to GST–abLIM fusion proteins. Three
different polypeptides expressed in E. coli and purified by affinity
chromatography were tested for the ability to associate with F-actin:
GST only (GST), GST fused to part of the dematin region of
abLIM (GST–dem), and GST fused to part of the LIM domain of
abLIM (GST–LIM). Each polypeptide was incubated with
(1actin) or without (2actin) actin under conditions that favor ac-
tin polymerization. After centrifugation to sediment F-actin, each
sample was separated into a supernatant (S) and pellet (P). Sam-
ples are indicated at the top of the SDS gel. Control incubations
with actin but without added fusion proteins were run in parallel
(far right panel). Mobilities of each fusion protein with the appro-
priate mass are indicated by filled arrowheads (right). Note the
presence of each fusion protein in the supernatant fraction in
2actin samples (left). Only GST–dem is enriched in the 1actin
pellet fraction, indicating cosedimentation of GST–dem, but not
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tides expressed using the rabbit reticulocyte lysate system
are larger than the predicted sizes of the respective iso-
forms (Fig. 8 a, lanes 1–3). At least part of this difference
is expected by comparison with dematin polypeptides: the
predicted sizes of the two dematin subunits are 43 and 45
kD as compared with the actual Mr on SDS-PAGE of 48
and 52 kD, respectively (Rana et al., 1993; Azim et al.,
1995).
There is a further discrepancy between the size of
abLIM-m and -l expressed in tissues compared with the re-
spective polypeptides expressed in vitro (Fig. 8 a). To test
the possibility that the difference between the predicted
mass (87.7 kD) and experimentally determined mass
(z105 kD) of the large isoform of abLIM results from
posttranslational modifications to the abLIM-l primary se-
quence, membrane extracts from murine rod inner seg-
ments were treated with enzymes to specifically alter ei-
ther abLIM protein glycosylation or phosphorylation.
Although abLIM glycosylation cannot be completely
ruled out, no shift in polypeptide mobility was observed
after exhaustive treatment with endoglycosidase F/N-gly-
cosidase and endoglycosidase H (data not shown). The
general effectiveness of the glycosidase treatment was
monitored by a concomitant shift in the mobility of rhodop-
sin, which is also present in the RIS extract and is known
to bear carbohydrate chains. In addition, the inclusion of
microsomal membranes in the in vitro translation mixture
(data not shown) had no effect on the size of the expressed
abLIM products, suggesting that abLIM is not a good sub-
strate for glycosylation. This is consistent with the null ef-
fect of deglycosylating agents on the tissue polypeptides.
In contrast, treatment of membrane extracts from mu-
rine rod inner segments with alkaline phosphatase causes
a large shift in the apparent mass of abLIM-l from 105 to
z95 kD (Fig. 8 a, lane 4, and Fig. 8 d, RIS1AP). This sug-
Figure 7. Quantitation of abLIM binding to actin filaments. As-
say mixtures containing different total amounts of GST–abLIM
polypeptide (putative actin-binding domain of abLIM, amino ac-
ids 585–778) were processed to separate bound abLIM in each
pellet fraction (P) from free abLIM in the supernatant fractions
(S). The derived values are plotted in a. The total amount of
abLIM added (mg) in each 60-ml reaction mixture is indicated
above each pair of gel lanes in b.
Figure 8. Characterization of expressed abLIM polypeptides. (a)
Comparison of abLIM polypeptides expressed in vitro and in
vivo. 35S-labeled polypeptides expressed in vitro in reticulocyte
lysates (a, lanes 1–3) are compared with abLIM polypeptides in
immunoblots of extracts from various tissues (a, lanes 5–7). The
additional bands below the major products in lanes 1–3 are prob-
ably due to internal initiation products from methionines 213,
324, 446, 582, and a cluster of nine methionines near the COOH
terminus (between amino acids 696–771). Both sets of polypep-
tides were run on the same gel and prestained mobility standards
were used to align the Western blot and the 35S-fluorogram. (b) A
silver-stained SDS gel profile (lanes 1–3) and immunoblot (lanes
4–6) of retinal fractions. (c) Immunoblot of cytoskeletal extracts
from various tissues. The SDS gel was overloaded to show minor
polypeptide species. (d) Immunoblot of retinal extracts incubated
for 15 min (lanes 2, 5, and 8), 30 min (lanes 3, 6, and 9), or 1 h
(lanes 4, 7, and 10) with/without the inclusion of alkaline phos-
phatase. Tissue extracts in all panels are cytoskeletal fractions
from heart, liver, kidney, lung, and brain. Mobility standards
(kD) are indicated at left of each panel. (Filled arrowhead)
abLIM-m; (open arrowhead) abLIM-l at z70 and z105 kD, re-
spectively. abLIM-specific antiserum was used at 1:5,000. No
staining was observed at 1:5,000 using preserum or serum ab-
sorbed with the GST–dem fusion protein (data not shown). RIS,
rod inner segments; ROS, rod outer segments; retina, whole ret-
ina; C, control (untreated) rod inner segment extract; RIS1AP,
RIS incubated with alkaline phosphatase; RIS–AP, RIS incu-
bated without addition of alkaline phosphatase; RIS1AP/Pi, RIS
treated with alkaline phosphatase in the presence of excess inor-
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gests that abLIM-l is highly phosphorylated in vivo in
adult light-adapted retinas and is consistent with the pre-
dicted presence of up to 36 potential phosphorylation sites
within the deduced primary amino acid sequence.
Dephosphorylation of the putative abLIM-l polypeptide
in rod inner segment preparations (Fig. 8 d, lanes 2–4)
brings the mobility of the putative abLIM-l isoform close
to that of the expressed variant. However, all of the in
vitro expressed polypeptides remain uniformly 2–3 kD
smaller than their respective counterparts in tissue ex-
tracts. This small residual size discrepancy is probably due
to a species difference since the polypeptides were ex-
pressed from the human sequence, while the extracts were
prepared from mouse tissues. We have subsequently de-
termined the complete cDNA sequence of the murine
abLIM-l isoform (data not shown) and find that the de-
duced murine amino acid sequence is 2.6 kD larger than its
human counterpart, largely due to an insertion of 28
amino acids between P348 and T349 of the human se-
quence. This insertion is within the dematin homology re-
gion and would be expected to affect the size of all three
isoforms, as observed in Fig. 8 a. Excluding the insert in
the murine sequence, the murine and human abLIM se-
quences are colinear and show a 90% overall amino acid
identity.
Subcellular Localization of abLIM
The biochemical fractionation of abLIM-l into the photo-
receptor inner segment fractions (Fig. 8 b) corresponds
well with the immunofluorescence staining pattern of the
abLIM COOH-terminal antigen in retina that shows
abLIM antigenicity concentrated in the inner segment and
outer plexiform layers of both adult murine and human
retinas (Fig. 9, c and f). This staining is not present in con-
trol sections treated either with preimmune rabbit serum
(Fig. 9 a) or abLIM-specific antiserum that has been pre-
absorbed with the GST–abLIM fusion protein (Fig. 9 b).
Nor does the abLIM-specific antibody staining pattern
change when the antiserum is preabsorbed with the GST-
only portion of the fusion protein (Fig. 9 e).
Subcellular localization of abLIM protein within stri-
ated muscle shows a regular and repetitive expression pat-
tern. abLIM protein within cardiac myocytes is regularly
spaced in a striped pattern approximately every 1.8 mm
along the myofibril axis in areas that contain relatively re-
laxed muscle fibers (Fig. 10 d, arrow). This pattern of
abLIM stripes coincides with the midpoint of the actin-
containing portion of the muscle fibers, a position equiva-
lent to the Z disk, as defined by the faint black stripe that
bisects the brightly stained F-actin stripes (Fig. 10 d, ar-
Figure 9. Localization of abLIM within
retinal tissue sections. Unfixed cryostat
sections prepared from adult murine reti-
nas (a–e) or an adult human retina (f). Sec-
tions in c and f were treated with abLIM-
specific antiserum at 1:500. Staining is
prominent in the inner segment layer (IS)
and outer plexiform layer (OPL). Staining
is abolished in control sections treated
with preimmune rabbit serum (a) or
abLIM-specific serum preabsorbed with
the GST–abLIM fusion protein (d). Stain-
ing is intact in control sections treated
with abLIM-specific antiserum preab-
sorbed with the GST-only portion of the
GST–abLIM fusion protein (e). All pri-
mary sera were used at 1:500. Secondary
antibodies are Cy3-conjugated anti–rab-
bit antibodies. Nomarski view of un-
stained adult mouse retina is shown for
reference.  OS, outer segment layer; ONL,
outer nuclear layer. Bar, 34 mm.The Journal of Cell Biology, Volume 138, 1997 584
Figure 10. Colocalization of abLIM proteins with cytoskeletal proteins in adult murine retina and cardiac muscle. Murine retinal sec-
tions (a–c) were used to colocalize F-actin and abLIM. F-actin was visualized using BODIPY FL-conjugated phallacidin (a, green) and
abLIM was visualized using specific primary antibodies followed by Cy3-conjugated secondary antibodies (b, red). Superimposed confo-
cal microscope images identify coincident F-actin and abLIM staining in the actin-rich outer limiting membrane (c). F-actin (green) and
abLIM (red) are similarly stained in unfixed sections of murine cardiac muscle (d–f). The periodicity of actin repeats varies across the
section with areas of highly contracted muscle at left (arrowhead) and relatively relaxed muscle fibers at right (arrow). In the areas of
the more relaxed fibers, abLIM is centered over the broad band of actin staining. Costaining of cardiac muscle with antibodies specific
for mouse anti–a-actinin (g, green) and rabbit anti-abLIM (h, red) confirms the coincidence of the two proteins at the Z disks in cardiac
muscle (i). Bars: (a–c) 20 mm; (d–f) 5.2 mm; (g–i) 5.6 mm.Roof et al. abLIM, an Actin-binding Double Zinc Finger Protein 585
row). The localization of abLIM immunoreactivity to the
Z disk of striated muscle is confirmed by the observed co-
incidence of abLIM staining with the a-actinin Z repeats
(Fig. 10, g–i). For comparison, actin costaining of retinal
sections (Fig. 10, a–c) shows that abLIM protein colocal-
izes with actin in regions of high actin concentration, such
as the adherens junctions of the outer limiting membrane
(Fig. 10 a, arrow). Thus, in both retina and striated muscle,
abLIM colocalizes with areas of high actin concentration,
consistent with the presence of a putative actin-binding
domain in this protein.
In murine brain, abLIM protein is present in cellular
processes located along the subpial and periventricular
surfaces of the brain, suggesting a particular concentration
within astrocyte processes. This is confirmed by costaining
with antibodies specific for glial fibrillary acidic protein
(GFAP), which is a relatively specific marker for astro-
cytes (Fig. 11 b). The nerve fiber layer of the retina, which
stains positively for GFAP, also stains strongly with
abLIM-specific antibodies (Fig. 12; data not shown), sug-
gesting that abLIM protein is a component of retinal as-
trocytes as well. However, in contrast with its localization
within both glial cells and photoreceptor neurons in the
retina, abLIM protein expression within the brain appears
to be largely restricted to glial cell processes. abLIM stain-
ing is not coincident with neuronal processes as indicated
by costaining with antibodies specific for the 68-kD neu-
rofilament polypeptide (Fig. 11, c and d, NF68).
abLIM Expression during Retinal Development
The developmental expression pattern of abLIM protein
within the photoreceptor layers of the retina suggests pos-
sible ways in which the actin-binding activity may be coor-
dinated with retinal development. At birth, murine photo-
receptor precursors express only small amounts of abLIM
protein. Between postnatal days 4–10, abLIM protein ex-
pression is detected at increasing levels within the elongat-
ing photoreceptor inner segments and within the develop-
ing outer plexiform layer (Fig. 12). After postnatal day 8,
abLIM is also expressed at high concentrations within the
outer limiting membrane. Thus, abLIM expression roughly
coincides with some important developmental landmarks
in retinal morphogenesis: the elongation of inner seg-
ments, the formation of the photoreceptor synaptic layer,
and the initiation of outer segment formation subsequent
to the formation of the adherens junction comprising the
outer limiting membrane.
Figure 11. Costaining of abLIM proteins and intermediate filament polypeptides in murine brain. Cryostat sections of murine brain
were costained with the following primary antibodies: (a and c) rabbit polyclonal anti-abLIM, (b) mouse monoclonal anti-GFAP, and
(d) mouse monoclonal anti-neurofilament 68-kD subunit (NF68). GFAP and abLIM are both localized to putative astrocyte processes
at the periventricular surface (a and b), while abLIM and NF68 are localized within distinct types of processes. Bar, 34 mm.The Journal of Cell Biology, Volume 138, 1997 586
Discussion
We have identified a novel protein with multiple isoforms
expressed in a wide range of cells and tissues. The proper-
ties of this protein suggest that it could play a role in estab-
lishing or altering cell morphology through actin binding
and/or participate in a signaling pathway involved in cellu-
lar differentiation.
Several lines of evidence suggest that abLIM protein
can function as an actin-binding protein in vivo: all vari-
ants of abLIM show strong sequence homology to a previ-
ously described actin-binding protein, dematin, with con-
servation of the specific dematin-like sequences that have
been implicated in its actin binding function (Azim et al.,
1995). An abLIM fusion protein that contains sequences
from the dematin homology region binds with high affinity
and high stoichiometry to actin filaments in vitro. Each of
the three identified abLIM isoforms expressed in vitro can
bind to actin filaments, showing that the amino-terminal
LIM domains do not inhibit actin binding through the
abLIM carboxy-terminal domain. Finally, the tissue local-
ization patterns of abLIM protein coincide with regions of
high actin concentration. For example, in the retina,
abLIM colocalizes with actin at adherens junctions in the
outer limiting membrane. In cardiac muscle, abLIM pro-
tein is highly enriched at or very close to the Z disk, an
area where actin filaments are anchored within the sar-
comere.
Comparison of the primary sequences of abLIM and de-
matin suggest that, while the actin-binding site(s) are
likely to be similar in the two molecules, if abLIM asserts
higher order control over actin cross-linking, this is achieved
by a different mechanism than for dematin. Dematin bun-
dles actin filaments by trimer formation putatively involving
a critical cysteine residue (Azim et al., 1995). This cysteine
is not conserved in the abLIM primary sequence. However,
since only the minimal backbone of a single LIM domain
is necessary and sufficient to achieve LIM protein interac-
tions both in vitro and in vivo (Feuerstein et al., 1994; Arber
and Caroni, 1996), any of the four NH2-terminal LIM do-
mains could dimerize. Thus, although we have shown that
the LIM domains from abLIM protein cannot themselves
bind to actin in vitro, LIM domains acting in combination
with a cytoskeleton-binding domain could permit more
complex actin associations in vivo and therefore mediate
changes in cell shape.
The mechanism by which abLIM could modulate cell
shape may be analogous to the dynamic changes attrib-
uted to dematin during erythropoiesis (Azim et al., 1995),
which are putatively controlled through reversible phos-
phorylation by cAMP kinase (Husain-Chishti et al., 1988,
1989). abLIM is a substrate for intracellular kinase(s) and
is highly phosphorylated in the retina under some physio-
logical conditions, such as light adaptation. Thus, although
the molecular mechanisms by which dematin and abLIM
can achieve actin cross-linking are probably distinct, re-
versible cytoskeletal modulation may be a property of
both molecules.
In addition to potential homodimer associations that
would cross-link actin filaments, the four abLIM double
zinc finger domains could also bridge the actin cytoskele-
ton to an array of cytoplasmic targets. LIM proteins have
previously been shown to bind both to heterologous LIM
proteins via LIM–LIM interactions (Sadler et al., 1992) as
well as to LIM-binding proteins that do not contain LIM
domains (Agulnick et al., 1996; Kuroda et al., 1996). This
suggests that abLIM could serve a more complex role in
cellular signaling pathways, perhaps similar to other LIM
proteins that belong to the class of LIM proteins that are
relatively large (.60 kD), that contain two to four LIM
domains, and that are found within the cell cytoplasm. The
two best characterized cytoplasmic LIM proteins from this
group are paxillin (Turner et al., 1991; Turner and Miller,
1994; Salgia et al., 1995) and zyxin (Sadler et al., 1992;
Crawford et al., 1994), each of which has a clearly defined
role in cellular differentiation and/or malignant transfor-
mation. Paxillin, a vinculin- and talin-binding protein
Figure 12. Developmental time course of abLIM expression in murine retinas. Unfixed cryostat sections of developing mouse retinas at
postnatal days 2, 4, 6, 8, and 10 were stained with abLIM-specific antibodies. Outer plexiform layer (OPL) staining is present after post-
natal day 6 (p6) and staining of dots in the outer limiting membrane becomes apparent within the inner segment layer (IS) at postnatal
days 8–10 (p8–p10). NF, nerve fiber layer. Bar, 20 mm.Roof et al. abLIM, an Actin-binding Double Zinc Finger Protein 587
(Crawford et al., 1994; Salgia et al., 1995), has been placed
within a signaling pathway that couples growth factor re-
ceptors via tyrosine kinases and SH2/SH3 binding se-
quences to the control of cell growth and maintenance of
the differentiated state (Fuortes et al., 1994; Turner and
Miller, 1994; Salgia et al., 1995). Zyxin, in combination
with another LIM protein to which it binds (CRP), is pos-
tulated to participate in a regulatory or signaling pathway
that is initiated via association with adhesion plaques
through binding to a-actinin (Sadler et al., 1992; Crawford
et al., 1994). It is probable that abLIM protein is also a bi-
functional protein–protein linker and, like zyxin and paxil-
lin, could participate in an undiscovered signaling pathway
either through heterologous LIM/LIM or LIM/LIM-bind-
ing protein interactions in combination with a cytoskeletal
association.
It is also possible that abLIM directly mediates the in-
teraction of other LIM proteins with the actin cytoskele-
ton. To date, abLIM is the only LIM protein with a dem-
onstrated ability to bind directly to actin filaments. As
such, abLIM could act as the central mediator for the in-
teraction of many different LIM proteins with microfila-
ments, particularly for the class of small LIM-only cytoskel-
eton-associated proteins that apparently lack a separate
cytoskeleton-binding domain (Arber et al., 1994; Arber
and Caroni, 1996; Stronach et al., 1996).
The ways in which such LIM-mediated interactions are
coordinated to produce specific developmental programs
and to determine specific cell fates are only beginning to
be understood. It appears that the coordinated expression
of several distinct LIM proteins from a multigene family is
central in the determination of cell fate for several classes
of motor neurons, both in developing chick (Tsuchida et
al., 1994) and zebrafish (Appel et al., 1995) embryos.
Based on these data, a general model for the determina-
tion of cell fate by LIM homeodomain proteins has been
proposed (Tsuchida et al., 1994; Lumsden, 1995): closely
related, but distinct, genes are expressed in unique cell-
specific combinations during differentiation of particular
cell lineages. In a similar way, the coordinated expression
of two distinct variants from the multigene family of CRP-
like proteins has been postulated to control different fac-
ets of myogenesis in Drosophila embryos (Stronach et al.,
1996).
The three abLIM isoforms could serve as a variation on
this basic theme by which LIM protein function is regu-
lated in vivo. It has been demonstrated, for a diverse set of
LIM domains, that the addition of a single LIM “cassette”
to a LIM-containing polypeptide can dramatically alter
the targeting and, presumably, function of the expressed
polypeptide in situ (Arber and Caroni, 1996). abLIM is the
first LIM protein to be discovered with multiple isoforms
that differ only by the insertion/deletion of one or more
LIM cassettes. Our data suggest that the abLIM-m poly-
peptide, which contains three LIM domains, is expressed
ubiquitously and at relatively high levels in all adult tis-
sues, including the retina. Superimposed upon this base-
line expression of abLIM-m in the retina is the photore-
ceptor-specific expression of the abLIM-l isoform, which
contains one additional LIM cassette. We do not know the
functional consequences of this cell-specific expression,
but it is likely that within photoreceptors abLIM-l could
compete for functional binding sites with the more widely
expressed abLIM variants, particularly abLIM-m. This
could have profound consequences for the activation or
inhibition of any signaling pathway in which either variant
participates. A molecule such as abLIM protein, which as-
sociates with the actin-rich adherens junctions as they are
being formed between developing photoreceptor cells and
Mueller glia, could coordinate the formation of these junc-
tions with subsequent steps in the morphogenesis of pho-
toreceptors, including the formation of the light-sensing
organelle, the outer segment. The coordinated expression
of three or more abLIM isoforms at different times during
development and/or in different tissues could provide a
mechanism by which abLIM proteins function in more
general aspects of cellular differentiation.
As probes specific for each abLIM isoform become
available and additional abLIM-binding partners are iden-
tified, it will be possible to define both the potential role of
abLIM in general cellular regulatory pathways as well as a
specific role in photoreceptor development and/or mor-
phogenesis. Ultimately, the cellular consequences of ge-
netic ablation of each abLIM isoform will reveal the im-
portance of such abLIM-associated pathways in vivo.
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